Evidence map›Paper›PMID 29238010›Full record

Observational studyJournal of atherosclerosis and thrombosis2018

Rationale and Descriptive Analysis of Specific Health Guidance: the Nationwide Lifestyle Intervention Program Targeting Metabolic Syndrome in Japan.

Kazuyo Tsushita, Akiko S Hosler, Katsuyuki Miura, Yukiko Ito, Takashi Fukuda, Akihiko Kitamura, Kozo Tatara

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Journal of atherosclerosis and thrombosis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 150 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Kazuyo TsushitaComprehensive Health Science Center, Aichi Health Promotion Public Interest Foundation.
Akiko S HoslerUniversity at Albany (SUNY) School of Public Health.
Katsuyuki MiuraShiga University of Medical Science.
Yukiko ItoTokyo Gakugei University.
Takashi FukudaNational Institute of Public Health.
Akihiko KitamuraTokyo Metropolitan Institute of Gerontology.
Kozo TataraJapan Public Health Association.
Aichi Health Promotion Foundation · JPJapan Industrial Safety and Health Association · JPShiga University of Medical Science · JPTokyo Gakugei University · JPTokyo Metropolitan Institute of Gerontology · JPUniversity at Albany, State University of New York · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimAll health insurers in Japan are mandated to provide Specific Health Checkups and Specific Health Guidance (SHG) focusing on metabolic syndrome (MetS) in middle-aged adults, beginning in 2008; intensive HG for individuals who have abdominal obesity and two or more additional MetS risk factors, and motivational HG for individuals with one risk factor. The aim of this study is to describe medium-term changes in health indexes for intensive and motivational HG groups using the National Database.

methodsWe compared changes of risk factors and initiation of pharmacological therapy over 3 yr between participants (n=31,790) and nonparticipants (n=189,726) who were eligible for SHG in 2008.

resultsBody weight reduction in intensive HG was 1.98 kg (participants) vs 0.42 kg (nonparticipants) in men (p<0.01) and 2.25 vs 0.68 kg in women (p<0.01) after 1 yr. In motivational HG, the respective reduction was 1.40 vs 0.30 kg in men (p<0.01) and 1.53 vs 0.42 kg in women (p<0.01). Waist circumference reduction was also greatest among participants in intensive HG (2.34 cm in men and 2.98 cm in women). These reductions were fairly unchanged over 3 yr and accompanied greater improvements in MetS risk factors in participants. We also detected significantly smaller percentages of SHG participants who initiated pharmacological therapy compared with nonparticipants.

conclusionParticipants in SHG showed greater improvements in MetS profiles with proportionally smaller pharmacological treatment initiations than did nonparticipants for 3 yr. Although selection bias may be present, this study suggests SHG would be a feasible strategy to prevent MetS and its sequelae.

Indexed as

Health PolicyAdultAgedBody WeightDatabases, FactualDecision MakingFemaleHealth PromotionHumansJapanLongitudinal StudiesMaleMetabolic SyndromeMiddle AgedMotivationObesity, AbdominalHealth checkupHealth GuidanceHealth PolicyMetabolic SyndromeNational Data Base

Identifiers

PMID29238010
PMCPMC5906184
OpenAlexW2773807345

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.